Delivery Order SPE2DB20D3103-SPE2DB24FM4N1
Award Date 1/29/24
Potential Completion Date 1/30/24
Potential Value $295K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award, valued at $15,275.33, is for the delivery of Biktarvy 50-200-25 MG Tablet, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of February 12, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $21,361.39 for the supply of Biktarvy 50-200-25 30S, a pharmaceutical product. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency that supports the Department of Defense. The contract has an ultimate completion date of December 27, 2023 and is a firm fixed-price delivery order. Amerisourcebergen holds a larger Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $79,048.15 for the supply of BIKTARVY 50-200-25 MG TABLET UU 30S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November...
- This federal contract award is for the delivery of pharmaceutical products and medical supplies to the U.S. government. The prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a Delivery Order (SPE2DX22FCEK5) valued at $92,495.09 by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). The contract covers the delivery of Biktarvy 50-200-25 mg tablets to support military and veterans' healthcare programs....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $18,218.68 firm-fixed-price delivery order is for the pharmaceutical product Biktarvy 50-200-25 mg Tablet, with an ultimate completion date of November 7, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- This federal contract award, valued at $5,393.34, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Biktarvy 50-200-25 mg tablets, a pharmaceutical product, to fulfill the medical supply requirements of the DLA. The contract is a delivery order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $21,494.92 for the supply of BIKTARVY 50-200-25 MG TABLET UU 30S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $31,391.54 firm-fixed-price delivery order is for Biktarvy 50-200-25 mg tablet prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $54,991.16 for the supply of BIKTARVY 50-200-25 MG TABLET. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of March 11, 2024. The contract is a firm-fixed-price delivery order with no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Firm Fixed Price Delivery Order worth $76,466.38 awarded by the Defense Logistics Agency (DLA). The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product, and has an ultimate completion date of March 1, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FM4N1Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $294,670.29, is for the delivery of Biktarvy 50-200-25 mg tablets. The IDC held by Amerisourcebergen with the DLA is valued at up to $999,999,999.00 and runs through November 2026, serving as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating it was awarded through full and open competition.
Generated 2/27/25, 1:27 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $294.7k | 1/29/24 |